MBB Public Markets I LLC Makes New $5.14 Million Investment in CME Group Inc. (NASDAQ:CME)

MBB Public Markets I LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 26,150 shares of the financial services provider’s stock, valued at approximately $5,141,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Capital International Investors grew its position in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. boosted its stake in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after acquiring an additional 1,309,097 shares during the last quarter. Capital World Investors grew its position in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares during the period. M&G Plc purchased a new stake in shares of CME Group in the 1st quarter worth $156,631,000. Finally, Assenagon Asset Management S.A. raised its holdings in CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after purchasing an additional 550,133 shares during the period. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CME. Royal Bank of Canada initiated coverage on CME Group in a report on Friday. They set a “sector perform” rating and a $235.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $212.54.

Get Our Latest Research Report on CME

CME Group Stock Down 0.1 %

CME opened at $218.30 on Friday. The company has a market capitalization of $78.60 billion, a PE ratio of 24.84, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55. The firm has a 50-day simple moving average of $209.70 and a two-hundred day simple moving average of $207.57. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $2.30 earnings per share. The firm’s revenue was up 12.7% on a year-over-year basis. Analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.